All articles by David Shlaes

ACSH article image
Too Little is Not Enough
( )
ACSH article image
Politics and the FDA
( )
ACSH article image
Coronavirus vs. Antibiotic Resistance
( )
ACSH article image
As for Infection Control, Is Medicare Helping?
( )
ACSH article image
FDA Revisits Community-Acquired Pneumonia
( )
ACSH article image
FDA Analysis of Antibiotic Development ... with Hubris!
( )
ACSH article image
Reach Out: Leave the Echo Chamber
( )
ACSH article image
Antibiotics: Back to the Future
( )
ACSH article image
The Keystone Cops vs. Coronavirus
( )
ACSH article image
COVID-19: What Have We Learned?
( )
ACSH article image
What Happened to the CDC?
( )
ACSH article image
Coronavirus: The US Debacle (Part 2)
( )
ACSH article image
Vaccines and Therapies for Coronavirus
( )
ACSH article image
Coronavirus: The US Debacle (Part 1)
( )
ACSH article image
Coronavirus: My Secret Hope
( )
ACSH article image
Coronavirus and Tetraphase
( )
ACSH article image
Coronavirus: An Event Foreseen
( )
ACSH article image
Long-Term Care, the Achilles Heel of American Healthcare
( )
ACSH article image
Stewardship vs. Financial Incentives: A False Choice
( )
ACSH article image
Where are the Professional Societies?
( )
ACSH article image
BARDA, Paratek and Pull Incentives: Funding Antibiotic Research?
( )
ACSH article image
Antibiotics: Europe or a Tapestry of Nations?
( )
ACSH article image
Antibiotics: Innovation or Clinical Utility?
( )
ACSH article image
The CDC's Report on Antibiotic Resistant Threats in the US
( )
ACSH article image
The Economic Conundrum for Antibacterial Drugs
( )
ACSH relies on donors like you. If you enjoy our work, please contribute.

Make your tax-deductible gift today!

 

 

Popular articles

ACSH Podcasts

Latest from Josh

Latest from Chuck